0.05Open1.50Pre Close12 Volume456 Open Interest7.00Strike Price2.14KTurnover0.00%IV0.45%PremiumOct 18, 2024Expiry Date1.90Intrinsic Value100Multiplier12DDays to Expiry0.04Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma5.56Leverage Ratio--Theta--Rho--Eff Leverage--Vega
CorMedix Stock Discussion
Dow Jones· 4 mins ago. CorMedix: DefenCath Catheter Lock Solution Is FDA Approved to Reduce Incidence of Catheter-Related Bloodstream Infections in Adult Patients With Kidney Failure >CRMD
Dow Jones· 2 mins ago
Benzinga· just
No comment yet